Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Hypogonadism × Alendronate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Osteoporosis 4 Prostatic Neoplasms 2 Hypogonadism 2 Breast Neoplasms 1

Interventions

Alendronate 2 Testosterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00177619 2014-02-11

Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)

University of Pittsburgh

Phase 3 Completed

Hypogonadism, Prostatic Neoplasms

NCT00048841 2010-03-02

Prevention of Osteoporosis in Men With Prostate Cancer

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 3 Completed

Hypogonadism, Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡